The Power of Connection: Leveraging Technology for Humanistic Medical Education

---

LIVEFace to FaceDHPAMA

Saturday, November 2, 2024, 9:00 AM - Sunday, November 3, 2024, 2:30 PM, Le Royal Méridien, Doha, Qatar

The rapid advancement of technologies, including artificial intelligence (AI), augmented reality (AR), and virtual reality (VR), is reshaping the landscape of medical practice. In this conference, we focus on the cutting-edge tools revolutionizing healthcare delivery and further outline how they could be used to leverage Medical Education. We will also explore the intersection between technology and humanistic science, which is critical for educating compassionate clinicians in the AI era.

1. Examine ethical issues related to the integration of AI in medical education.
2. Discuss a conceptual model of Precision Education and evaluate current innovations that enhance personalized learning in medical training.
3. Analyze current technology trends in AR and VR applicable to healthcare education and practice.
4. Demonstrate an enhanced understanding of AI principles and their applications in medical education.
5. Explain how the integration of art and medicine enhances observational skills, communication abilities, and fosters cultural awareness in medical practice.

USD 150 / QAR 544.5

Registration Deadline: October 29th, 2024 / Registration and Cash payment is accepted onsite on November 2nd and 3rd from 8am.

Changes or Cancellations
1- Name changes or substitutions are not permitted.
2- All cancellation and refund requests must be made in writing and submitted via email [email protected] .
3- For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
4- We will attempt to process the refund within 30 days of receiving any cancellation request.
5- Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to [email protected] 

 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 8.25 hours.

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Thurayya Arayssi, MD, Anna Halama, PhD, Kadhija Ziana Vamanjoor, BDS, MFDS, RCS, Mark D Santos, RN, BSN, CNS, Nicola Lategan, RT, BSc, Salman Al Jerdi, MD, Deema Al-Sheikhly, MRes, MEHP, Mohamed Ali Hammami, MBA, Aicha Hind Rifai, MD, Nafe Atari, Mushtaq Bukhari, Mahmood Dualeh, MBA/MSTIS, MBA, MSTIS, PMP, Moune Jabre, MD, Frantzeska Gkioka, MBA

Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Scientific Planning Committee: Leena Amine, PharmD
Disclosed the following financial relationship:
Consulting fee, Wolters Kluwer
All of the relevant financial/non-financial relationships with for-profit/not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Scientific Planning Committee: Liam J Fernyhough, MD
Disclosed the following financial relationship:
Flights and accommodation paid for conference- Biomarin 
Honoraria- Roche
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
The financial/non-financial relationships are not relevant
Will not be discussing unlabeled/unapproved use of drugs or products

Scientific Planning Committee: Jamie Gray, MLS, MS
Disclosed the following financial relationship:
Stocks or stock options, excluding diversified mutual funds-Colgate-Palmolive|Stocks or stock options, excluding diversified mutual funds-Proctor & Gamble|Stocks or stock options, excluding diversified mutual funds-Intuitive Surgical Inc
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Course Directors: Thurayya Arayssi, MD, Anna Halama, PhD
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty/ Moderators: Thurayya Arayssi, MD, Anna Halama, PhD, Javaid Sheikh, MD, Abdullatif Al-Khal, MD, Ibrahim Janahi, MD,  Sanjay Desai, MD, MACP, Kirsten Ostherr, PhD, Marcos S Rojas Pino, MD,  Jonathan St George, MD, Lauren A Toomer, MFA, Matteo Zallio, PharmD, Abdulaziz Yousef, Bachelor in Business Administrations, Deema Al-Sheikhly, MRes, MEHP, Stella Major, MBBS, Laudy Mattar, Educator, Salman Al Jerdi, MD, Aicha Hind Rifai, MD, Mohamed Ali Hammami, MBA, Shaymaa Dib, Master Degree, Nasnass Nassir, BHMS,  Monsur Ahmmad, BBS
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty/ Moderators: Nada OBrien, PhD
Disclosed the following financial relationship:
Employment, Magic Leap
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty/ Moderators: Effy Vayena, PhD
Disclosed the following financial relationship:
Honoraria-Bayer
Advisor - Merck & Honoraria - Roche
All of the relevant financial/non-financial relationships with any for-profit/ not-for-profit organizations have been mitigated
The financial/non-financial relationships are not relevant
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty/ Moderators: Liam J Fernyhough, MD
Disclosed the following financial relationship:
Flights and accommodation paid for conference- Biomarin 
Honoraria- Roche
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
The financial/non-financial relationships are not relevant
Will not be discussing unlabeled/unapproved use of drugs or products

Independent Content Reviewer (ICR): Anna Halama, PhD

Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Administrative Contact: Aaliya Chougle, MA
Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

This CPD activity is supported by financial and/or in-kind support from the following sponsors:

IRIS Technologies

TechViz

Gaumard Scientific